Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Frontline
FRO
$8.68B
| $4.73M | ﹤0.01% |
207,009
-259,421
| -56% | -$6.11M |
|
|
HBI
2127
DELISTED
Hanesbrands
HBI
| $4.73M | ﹤0.01% |
643,497
+515,356
| +402% | +$3.08M |
|
2128
Albany International
AIN
$2.13B
| $4.73M | ﹤0.01% |
53,227
+40,101
| +306% | +$3.53M |
|
2129
Urban Edge Properties
UE
$2.85B
| $4.73M | ﹤0.01% |
221,007
+171,478
| +346% | +$3.45M |
|
2130
AptarGroup
ATR
$8.7B
| $4.73M | ﹤0.01% |
29,499
-13,697
| -32% | -$2.03M |
|
2131
Pliant Therapeutics
PLRX
$65M
| $4.73M | ﹤0.01% |
421,499
+78,575
| +23% | +$983K |
|
2132
PUT
Vipshop
VIPS
$7.47B
| $4.72M | ﹤0.01% |
300,000
| – | – |
|
2133
Vericel Corp
VCEL
$2.36B
| $4.71M | ﹤0.01% |
111,527
+66,082
| +145% | +$3.14M |
|
2134
Astera Labs
ALAB
$62B
| $4.71M | ﹤0.01% |
89,911
+89,123
| +11,310% | +$4.18M |
|
2135
Adient
ADNT
$1.65B
| $4.7M | ﹤0.01% |
208,239
+116,518
| +127% | +$2.67M |
|
2136
Levi Strauss
LEVI
$9.48B
| $4.7M | ﹤0.01% |
215,403
+8,356
| +4% | +$158K |
|
2137
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $4.69M | ﹤0.01% |
50,128
-324,073
| -87% | -$29.5M |
|
2138
ArcBest
ARCB
$3.23B
| $4.68M | ﹤0.01% |
43,134
+33,386
| +342% | +$3.67M |
|
2139
Chewy
CHWY
$9.87B
| $4.67M | ﹤0.01% |
159,293
+43,910
| +38% | +$1.17M |
|
2140
American Healthcare REIT
AHR
$10.6B
| $4.65M | ﹤0.01% |
178,316
+102,588
| +135% | +$2M |
|
2141
Bread Financial
BFH
$4.48B
| $4.65M | ﹤0.01% |
97,658
+53,529
| +121% | +$2.73M |
|
2142
Simpson Manufacturing
SSD
$7.91B
| $4.62M | ﹤0.01% |
24,179
+7,155
| +42% | +$1.29M |
|
2143
CALL
Edwards Lifesciences
EW
$51.1B
| $4.62M | ﹤0.01% |
70,000
-130,000
| -65% | -$9.45M |
|
2144
WIX.com
WIX
$2.79B
| $4.61M | ﹤0.01% |
27,547
+10,172
| +59% | +$1.64M |
|
2145
CALL
Strategy Inc
MSTR
$35.7B
| $4.6M | ﹤0.01% |
27,300
+300
| +1% | +$42.9K |
|
2146
Chesapeake Utilities
CPK
$3.21B
| $4.6M | ﹤0.01% |
37,048
+28,673
| +342% | +$3.35M |
|
2147
Recursion Pharmaceuticals
RXRX
$1.76B
| $4.6M | ﹤0.01% |
697,432
+304,278
| +77% | +$2.18M |
|
|
IBTX
2148
DELISTED
Independent Bank Group, Inc.
IBTX
| $4.58M | ﹤0.01% |
79,414
+33,213
| +72% | +$1.81M |
|
2149
Rocket Companies
RKT
$38.7B
| $4.57M | ﹤0.01% |
238,323
+137,441
| +136% | +$2.41M |
|
2150
Four Corners Property Trust
FCPT
$2.78B
| $4.57M | ﹤0.01% |
156,021
+81,565
| +110% | +$2.25M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.